Found: 9
Select item for more details and to access through your institution.
Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 129, doi. 10.3390/vaccines12020129
- By:
- Publication type:
- Article
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 55, doi. 10.3390/vaccines12010055
- By:
- Publication type:
- Article
A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1442160
- By:
- Publication type:
- Article
Identification of CD16-2, a novel mouse receptor homologous to CD16/FcγRIII.
- Published in:
- Immunogenetics, 2002, v. 54, n. 7, p. 463, doi. 10.1007/s00251-002-0486-0
- By:
- Publication type:
- Article
Diversity of Immunoglobulin Light Chain Genes in Non-Teleost Ray-Finned Fish Uncovers IGL subdivision into Five Ancient Isotypes.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01079
- By:
- Publication type:
- Article
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA.
- Published in:
- International Immunology, 2011, v. 23, n. 1, p. 43, doi. 10.1093/intimm/dxq456
- By:
- Publication type:
- Article
FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features.
- Published in:
- European Journal of Immunology, 2002, v. 32, n. 1, p. 87, doi. 10.1002/1521-4141(200201)32:1<87::AID-IMMU87>3.0.CO;2-#
- By:
- Publication type:
- Article
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern.
- Published in:
- Cell Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41421-021-00340-8
- By:
- Publication type:
- Article
VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 6, p. 895, doi. 10.3390/jpm12060895
- By:
- Publication type:
- Article